ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) has announced that Chairman and CEO Mick Farrell and Chief Medical Officer Dr. Carlos Nunez will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for Wednesday, September 4, 2024, at approximately 10:00 a.m. EDT at the New York Marriott Marquis.
Investors and interested parties can access the live, audio-only webcast through ResMed's investor relations website. A replay of the webcast will be available for 30 days following the event, accessible approximately 24 hours after the live session ends.
ResMed (NYSE: RMD, ASX: RMD) ha annunciato che il Presidente e CEO Mick Farrell e il Direttore Medico Dr. Carlos Nunez parteciperanno a un incontro informale durante il 22° Conferenza Annua Globale sulla Salute di Morgan Stanley. L'evento è programmato per mercoledì 4 settembre 2024, alle circa 10:00 EDT presso il New York Marriott Marquis.
Gli investitori e le parti interessate possono accedere al webinar audio in diretta attraverso il sito web delle relazioni con gli investitori di ResMed. Un replay del webinar sarà disponibile per 30 giorni dopo l'evento, accessibile circa 24 ore dopo la conclusione della sessione dal vivo.
ResMed (NYSE: RMD, ASX: RMD) ha anunciado que el Presidente y CEO Mick Farrell y el Director Médico Dr. Carlos Nunez participarán en un charla en la chimenea durante la 22ª Conferencia Global Anual de Salud de Morgan Stanley. El evento está programado para miércoles 4 de septiembre de 2024, aproximadamente a las 10:00 a.m. EDT en el New York Marriott Marquis.
Los inversores y partes interesadas pueden acceder a la transmisión en vivo solo de audio a través del sitio web de relaciones con inversores de ResMed. Una repetición de la transmisión estará disponible durante 30 días después del evento, accesible aproximadamente 24 horas después de que finalice la sesión en vivo.
ResMed (NYSE: RMD, ASX: RMD)는 회장 겸 CEO Mick Farrell 및 최고 의료 책임자 Dr. Carlos Nunez가 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에서 화로 대화에 참여할 것이라고 발표했습니다. 이 행사는 2024년 9월 4일 수요일에 오전 10시 EDT에 뉴욕 매리엇 마퀴스에서 열릴 예정입니다.
투자자와 관계자는 ResMed의 투자자 관계 웹사이트를 통해 실시간 오디오 방송에 접근할 수 있습니다. 생방송이 종료된 후 약 24시간 뒤부터 30일 동안 다시 방송을 시청할 수 있습니다.
ResMed (NYSE: RMD, ASX: RMD) a annoncé que le Président et CEO Mick Farrell et le Directeur Médical Dr. Carlos Nunez participeront à un chat au coin du feu lors de la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. L'événement est prévu pour mercredi 4 septembre 2024, à environ 10h00 EDT au New York Marriott Marquis.
Les investisseurs et parties intéressées peuvent accéder à la diffusion audio en direct via le site des relations investisseurs de ResMed. Un replay de la diffusion sera disponible pendant 30 jours après l'événement, accessible environ 24 heures après la fin de la session en direct.
ResMed (NYSE: RMD, ASX: RMD) hat angekündigt, dass Vorsitzender und CEO Mick Farrell sowie der Chief Medical Officer Dr. Carlos Nunez an einem Feuerstelle-Gespräch auf der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley teilnehmen werden. Die Veranstaltung ist für Mittwoch, den 4. September 2024, um etwa 10:00 Uhr EDT im New York Marriott Marquis angesetzt.
Investoren und Interessierte können die live Audioübertragung über die Investor Relations-Website von ResMed zugreifen. Eine Wiederholung der Übertragung wird für 30 Tage nach dem Event verfügbar sein, ca. 24 Stunden nach dem Ende der Live-Session zugänglich.
- None.
- None.
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, beginning at approximately 10:00 a.m. (Eastern Daylight Time) at the New York Marriott Marquis in New York, NY.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When and where is ResMed (RMD) participating in the Morgan Stanley Global Healthcare Conference?
Who will represent ResMed (RMD) at the Morgan Stanley healthcare conference?
How can investors access ResMed's (RMD) presentation at the Morgan Stanley conference?
